临床分离气单胞菌喹诺酮类的耐药机制研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

北京市自然科学基金( 7164249);首都卫生发展科研专项(2021-1C-3014)


Mechanism of resistance to quinolones in A eromonas species isolated from clinical patients
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    摘要:目的探讨临床分 离气单胞菌属细茵(Aeromonas spp. )喹诺酮类药物耐药机制。方法收集从北京友谊医院2017年腹泻患者粪便标本中分离的气单胞菌,采用微量肉汤稀释法检测其对喹诺酮类药物的敏感性,提取菌株核酸进行PCR扩增,测序分析气单胞茵喹诺酮耐药决定区(quinolone-resistancedeter mining region, QRDR)及喹诺酮耐药质粒相关( plasmid-mediated quinolone resistance, PMQR)基因。结果共收集 111株气单胞菌,其中7株(6.3%)对萘啶酸(NAL)和环丙沙星(CIP )均耐药,54株(48.6%)对NAL耐药但对CIP敏感,50株(45.0%)对NAL和CIP均敏感。QRDR测序结果显示,NAL耐药菌株gyrA基因第83位发生丝氨酸(Ser)突变,突变为异亮氨酸(le)、缬氨酸(Val)或酪氨酸(Tyr)。对NAL-CIP耐药的菌株中,除了 gyrA基因突变外,parC基因第87位Ser突变为Ile。 CIP 敏感的104株菌株中,仅有7株parC基因第87位Ser突变。PMQR基因检测结果显示,QnrS基因检出率为7.2%(8株) ,aac(6')-lb-cr 基因检出率为6.3%(7株),且QnrS和aac(6' )-1b-cr基因检出 主要集中在CIP耐药菌株中,CIP耐药菌株PMQR基因检出率为85.7%。结论气单胞菌喹诺酮低水平耐药主要与 gyrA基因第第83位突变或QnurS基因有关。gyrA基因第83位突变和parC基因第87位突变Ser87lle联合PMQR基因存在时,可能与气单胞茵对喹诺酮的高水平耐药相关。

    Abstract:

    Abstract: Objective To investigate the mechanism of quinolone resistanceof Aeromonas spp. isolated from cdinical patients. Methods The Aeromonas strains isolated from feces specimen of diarrheal outpatients in Beijing Friendship Hospital during 2017 were subjected to the susceptibility test to quinolones by microbroth dilution method. PCR were performed to extract the mucleic acids of the strains.The genes of qui nolone-resistance-determining region ( QRDR) of Aeromonas species and plasmid-mediated quinolone resistance ( PMQR) on chromosome were analyzed by sequencing. Results Of the 111 collected strains, 7( 6.3% ) strains were resistant to ciprofloxacin ( CIP)-nalidixic acid (NAL), 54( 48.6%) were resistant to NAL, but sensitive to CIP, and 50( 45.0%) were sensitive to both CIP-NAL. The sequence of QRDR showed that Ser831le/Val/Tyr mutation on gyrA was screened in NAL-resistant strains. In addition to mutation of gyrA, Ser87lle mutation of gene parC was identifed in all NAL-CIP-resistant strains. In the 104 CIP-sensitive strains, Ser87Ile mutation of parC was only found in 7 strains. The results of PMQR gene sequencing for these strains showed that detectable rate of gene QnrS was 7.2% ( 8 strains), aac(6' )-Ib-cr was 6.3% (7 strains). Most of QnrS and aac(6' )-Ib-cr were found in CIP-resistant strains. PMQR-positive strains constuted 85.7% of the CIP-resistant strains. Concusion The Ser83 mutation of gene gyrA or QnrS may relate with low levels of quinolone resistance of these strains. The gene PMQR coupled with Sr831le/Val/Tyr mutation in gyrA and Ser87Ile mutation in purC may give rise to high level of quinol oneresistance for Aeromonas app.

    参考文献
    相似文献
    引证文献
引用本文

赵高余,程敬伟,周妍妍.临床分离气单胞菌喹诺酮类的耐药机制研究[J].临床检验杂志,2023,41(09):646-650

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2023-03-10
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-12-01
  • 出版日期:
文章二维码
您是第位访问者  苏ICP备13058113号-3
苏公网安备32010202012004号
主管单位:江苏省医学会  出版单位:临床检验杂志
单位地址:江苏省南京市中央路42号  邮编:210008
电话:025-83620683 E-MAIL:lcjyzz@163.com
技术支持:北京勤云科技发展有限公司